CORVUS PHARMACEUTICALS, INC. (CRVS) Files An 8-K Other Events
Item 8.01 Other Events.

On November 11, 2016, Corvus Pharmaceuticals, Inc. issued a press release announcing clinical data with lead checkpoint inhibitor CPI-444, in connection with the presentations of such data at the Society for Immunotherapy of Cancer’s (SITC) 31st Annual Meeting and Associated Programs. The full text of the press release is filed as Exhibit 99.1 hereto and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

Reference is made to the Exhibit Index attached hereto.